Hallal David — SEC Form 4 filings
SEC reporting owner CIK 1457477. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-07 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 202,747 shares, $5,135,243 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 57,450 shares @ $42.70 ($2,453,115) in Scholar Rock Holding Corp, filed 2026-01-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | Chief Executive Officer, Director | 7 | — | 2 legs · 88,065 sh · $3,970,838 | 7 |
| iTeos Therapeutics, Inc. (ITOS) | Director | 3 | — | 3 legs · 114,682 sh · $1,164,405 | 9 |
| Kalaris Therapeutics, Inc. (KLRS) | Director | 3 | — | — | 3 |
| Seer, Inc. (SEER) | Director | 1 | — | — | 1 |
Form 4 filings — Hallal David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | Scholar Rock Holding Corp (SRRK) | Sale (S): 30,615 @ $49.57 | EDGAR |
| 2026-02-11 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 128,004 @ $0 | EDGAR |
| 2026-01-15 | 4 | Scholar Rock Holding Corp (SRRK) | Sale (S): 57,450 @ $42.70 | EDGAR |
| 2025-10-09 | 4 | Scholar Rock Holding Corp (SRRK) | Gift (G): 205,000 @ $0 | EDGAR |
| 2025-08-29 | 4 | iTeos Therapeutics, Inc. (ITOS) | Disposition to issuer (D): 25,140 (derivative) · Disposition to issuer (D): 146,160 (derivative) | EDGAR |
| 2025-06-06 | 4 | iTeos Therapeutics, Inc. (ITOS) | Option exercise (M): 38,227 @ $4.30 · Sale (S): 38,227 @ $10.07 · Option exercise (M): 38,227 @ $4.30 · Sale (S): 38,227 @ $10.15 · Option exercise (M): 38,228 @ $4.30 · Sale (S): 38,228 @ $10.24 · +3 more | EDGAR |
| 2025-05-06 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 275,167 (derivative) @ $0 | EDGAR |
| 2025-04-29 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 250,000 @ $0 · Grant/award (A): 1,250,000 @ $0 | EDGAR |
| 2025-04-11 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 13,500 @ $0 · Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Seer, Inc. (SEER) | Grant/award (A): 58,178 @ $0 | EDGAR |
| 2024-06-13 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 24,200 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Allovir, Inc. (ALVR) | Grant/award (A): 35,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1457477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →